SR-4980

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSR-4980
Drug Alias NameCDB-3146
ClassificationOther
Mechanisms of ActionTestosterone congeners inhibitors
TargetsTestosterone congeners
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSri International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSri International
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A